Inhibition of the TLR9-dependent p38 MAPK signaling pathway improves the pathogenesis of primary Sjogren's syndrome in the NOD/Ltj mouse.

, , , ,

Journal of biological regulators and homeostatic agents Vol. 35 (3) : 1103-1108 • May 2021

No abstract available for this paper

No clinical trial protocols linked to this paper

Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.

PICO extraction requires an abstract.

PMID: 34034463

DOI: 10.23812/21-154-L [doi]

Publication Year: 2021

Language: e, n, g

No associated datasets or code repositories found for this paper.

Related paper suggestions will be available in future updates.